• Colostrum Pathogenic Recognition Protein, CPRP, will attach to non-specific antigens in gut, enter the gut mucous membrane and release signals to immune cells, which stimulates immune cells and induce the immunity against antigens.
  • Instead of enhancing the cell antioxidant ability or stimulating the immune cells, CPRP can induce antibody IgA production. 
  • Now, this protein has been applied into the treatment of human influenza, enterovirus, and common cold, which all shows the positive results. 
  • We are now conducting the clinic theory of human influenza and enterovirus.

Sales Markets

Middle East Region (e.g. UAE); Oceania; North America (USA, Canada); Africa; Central America (e.g. Mexico); East Asia (e.g. China, Japan, Korea); Europe - EU countries; Europe - non EU (e.g. UK, Russia, ex-CIS countries); South America (e.g. Brazil, Colombia); South Asia (e.g. India, Pakistan, Sri Lanka); South East Asia (e.g. Thailand, Philippines, Singapore)

Primary business activity


Contact information




View All Contact Info

Categories affiliated with Sanshin Nutrition Technology Co., Ltd.